Yasserged
@yasserged
Followers
83
Following
36
Statuses
36
GU Medical Oncologist @hopkinskimmel Irish Trained Medical Oncologist Former GU Oncology Fellow @MSKCC Views are my own....
Baltimore, Maryland
Joined January 2019
RT @katy_beckermann: 🚨 New AI Tool for Immunotherapy Prediction! 🧠💊 A deep learning model predicts response to ICI in advanced NSCLC using…
0
1
0
RT @Sid423: Coming from a patient point of view this is big stuff coming from @DanaFarber @YaleCancer @BraunMDPhD and many others!
0
5
0
@nirmishsingla @JAMA_current @DrNDisis @JAMAOnc @AdityaBagrodia @CDFankhauser @HopkinsMedicine @brady_urology @AmerUrological @UroOnc @Uroweb @TestesCancer @TCSociety Honored to contribute to this Review with outstanding co-authors @nirmishsingla @AdityaBagrodia @CDFankhauser Ezra Baraban
0
0
1
Our paper on IO combinations in metastatic translocation RCC is now online. Great collaborative work and addition to treatment outcomes in this rare entity. @nirmishsingla @montypal @KotechaMD @MattZibelman
2
13
39
RT @nirmishsingla: Special thanks to Drs. Steven Schenkel & Kristin Walter @JAMA_current and @DrNDisis @JAMAOnc for the unique opportunity,…
0
5
0
RT @maughanonc: Lots to learn from this and other ongoing trials in papillary kidney cancer. S1500 and others show us that it’s possible —…
0
7
0
RT @nirmishsingla: Special shout out to co-surgeons @YWLum @wrburnsmd @hopkinssurgery and med onc @yasserged @hopkinskimmel So fortunate to…
0
3
0
RT @kidneycan: Can’t miss! The @OncJournal #KCRS24 abstract supplement is out! 🔗 #KidneyCancer #RCC #Acceleratin…
0
13
0
RT @DrChoueiri: #TiNivo2 results are out —adding PD1 inhibitor nivolumab simply does not help after rechallenge /progression on prior immun…
0
58
0
RT @yasserged: Our paper on liver TACE and immunotherapy in RCC is now online. Great job by Jeffrey Schneider @MarkowskiGUOnc
@drchristosMD…
0
2
0
Our paper on liver TACE and immunotherapy in RCC is now online. Great job by Jeffrey Schneider @MarkowskiGUOnc
@drchristosMD via @https://twitter.com/AmericanJIR
0
2
6
RT @OncoAlert: Just Out on @TheLancetOncol New findings from the PROSPER EA8143 trial Perioperative nivolumab before nephrectomy, followed…
0
9
0
RT @ZiadBakouny: Awesome talk by co-fellow Sahil Doshi @MSK_DeptOfMed reporting data from a multi-institution cohort to evaluate first line…
0
17
0
Our paper on survival outcomes and molecular drivers among Hispanic and non Hispanic patients with testicular cancer is now in press. Great work by Michael Rezaee @nirmishsingla @UrolOncol
0
1
5
RT @neerajaiims: Ab#4512 @ASCO #ASCO24 by #SahilDoshi👉👉Analysis of outcomes w/ 1L systemic Rx in chromophobe mRCC #…
0
20
0
RT @DrChoueiri: 1/ The long-awaited OS results from #KEYNOTE-564 are out @NEJM! The 1st phase 3 trial to demonstrate a survival benefit for…
0
212
0
RT @brady_urology: Sue was shocked to find her pain, weakness and broken bones were the result of cancer that had spread from her #kidney.…
0
5
0
RT @nirmishsingla: Thanks @GUOncologyNow for highlighting our work published in @UrolOncol led by @brady_urology @HopkinsMedicine @UroOnc f…
0
2
0
RT @nirmishsingla: Thanks @UrolOncol for highlighting our work from @brady_urology @HopkinsMedicine led by @UroOnc fellow @mike_rezaee
0
5
0
RT @UrologyTimes: In a session at #IKCSNA23, Dr. Yasser Ged discussed emerging treatment approaches for patients with metastatic translocat…
0
2
0